Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM, Atkins MB, Thompson JA, Coit DG, Byrd D, Desmond R, Zhang Y, Liu PY, Lyman GH, Morabito A.

J Clin Oncol. 2001 Aug 15;19(16):3622-34.

PMID:
11504744
2.

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF.

J Clin Oncol. 2001 Aug 15;19(16):3635-48. Review.

PMID:
11504745
3.

An evidence-based staging system for cutaneous melanoma.

Balch CM, Soong SJ, Atkins MB, Buzaid AC, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF.

CA Cancer J Clin. 2004 May-Jun;54(3):131-49; quiz 182-4. Review.

4.

A population-based validation of the American Joint Committee on Cancer melanoma staging system.

Gimotty PA, Botbyl J, Soong SJ, Guerry D.

J Clin Oncol. 2005 Nov 1;23(31):8065-75.

PMID:
16258105
5.
6.

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.

Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Ding S, Byrd DR, Cascinelli N, Cochran AJ, Coit DG, Eggermont AM, Johnson T, Kirkwood JM, Leong SP, McMasters KM, Mihm MC Jr, Morton DL, Ross MI, Sondak VK.

J Clin Oncol. 2010 May 10;28(14):2452-9. doi: 10.1200/JCO.2009.27.1627.

7.

Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients.

Rousseau DL Jr, Ross MI, Johnson MM, Prieto VG, Lee JE, Mansfield PF, Gershenwald JE.

Ann Surg Oncol. 2003 Jun;10(5):569-74.

PMID:
12794025
8.

Final version of 2009 AJCC melanoma staging and classification.

Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm MC Jr, Morton DL, Ross MI, Sober AJ, Sondak VK.

J Clin Oncol. 2009 Dec 20;27(36):6199-206. doi: 10.1200/JCO.2009.23.4799.

9.

Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.

Murali R, Haydu LE, Long GV, Quinn MJ, Saw RP, Shannon K, Spillane AJ, Stretch JR, Kefford RF, Thompson JF, Scolyer RA.

Ann Surg Oncol. 2012 Jun;19(6):1782-9. doi: 10.1245/s10434-012-2265-y.

PMID:
22350600
10.

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.

Buzaid AC, Ross MI, Balch CM, Soong S, McCarthy WH, Tinoco L, Mansfield P, Lee JE, Bedikian A, Eton O, Plager C, Papadopoulos N, Legha SS, Benjamin RS.

J Clin Oncol. 1997 Mar;15(3):1039-51.

PMID:
9060544
11.

The revised American Joint Committee on Cancer staging system for melanoma.

Thompson JA.

Semin Oncol. 2002 Aug;29(4):361-9.

PMID:
12170439
12.
13.

Prognostic value of size of lymph node metastases in patients with cutaneous melanoma.

Buzaid AC, Tinoco LA, Jendiroba D, Tu ZN, Lee JJ, Legha SS, Ross MI, Balch CM, Benjamin RS.

J Clin Oncol. 1995 Sep;13(9):2361-8.

PMID:
7666095
14.

A new American Joint Committee on Cancer staging system for cutaneous melanoma.

Balch CM, Buzaid AC, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Houghton A Jr, Kirkwood JM, Mihm MF, Morton DL, Reintgen D, Ross MI, Sober A, Soong SJ, Thompson JA, Thompson JF, Gershenwald JE, McMasters KM.

Cancer. 2000 Mar 15;88(6):1484-91.

PMID:
10717634
15.

The new melanoma staging system.

Kim CJ, Reintgen DS, Balch CM; AJCC Melanoma Staging Committee..

Cancer Control. 2002 Jan-Feb;9(1):9-15. Review.

PMID:
11907461
16.

Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.

Thompson JF, Soong SJ, Balch CM, Gershenwald JE, Ding S, Coit DG, Flaherty KT, Gimotty PA, Johnson T, Johnson MM, Leong SP, Ross MI, Byrd DR, Cascinelli N, Cochran AJ, Eggermont AM, McMasters KM, Mihm MC Jr, Morton DL, Sondak VK.

J Clin Oncol. 2011 Jun 1;29(16):2199-205. doi: 10.1200/JCO.2010.31.5812. Erratum in: J Clin Oncol. 2011 Jul 20;29(21):2949.

17.

Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma.

Ben-Porat L, Panageas KS, Hanlon C, Patel A, Halpern A, Houghton AN, Coit D.

Cancer. 2006 Jan 1;106(1):163-71.

18.

Prognostic factors in 1,521 melanoma patients with distant metastases.

Barth A, Wanek LA, Morton DL.

J Am Coll Surg. 1995 Sep;181(3):193-201.

PMID:
7670677
19.

Reflecting on the 2001 American Joint Committee on Cancer Staging System for melanoma.

Retsas S, Mastrangelo MJ.

Semin Oncol. 2007 Dec;34(6):491-7. Review.

PMID:
18083372
20.

Prognosis associated with cutaneous melanoma metastases.

Pan Y, Haydon AM, McLean CA, McDonald PB, Kelly JW.

Australas J Dermatol. 2015 Feb;56(1):25-8. doi: 10.1111/ajd.12293.

PMID:
25688698
Items per page

Supplemental Content

Support Center